India · Delayed Price · Currency is INR Nath Bio-Genes (India) Statistics
Total Valuation
BOM:537291 has a market cap or net worth of INR 2.82 billion. The enterprise value is 4.36 billion.
| Market Cap | 2.82B |
| Enterprise Value | 4.36B |
Important Dates
The last earnings date was Saturday, January 31, 2026.
| Earnings Date | Jan 31, 2026 |
| Ex-Dividend Date | Aug 14, 2025 |
Share Statistics
| Current Share Class | 19.00M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.82% |
| Shares Change (QoQ) | -2.85% |
| Owned by Insiders (%) | 9.57% |
| Owned by Institutions (%) | 2.23% |
| Float | 6.28M |
Valuation Ratios
The trailing PE ratio is 6.53.
| PE Ratio | 6.53 |
| Forward PE | n/a |
| PS Ratio | 0.63 |
| PB Ratio | 0.41 |
| P/TBV Ratio | 0.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 10.11 |
| EV / Sales | 0.98 |
| EV / EBITDA | 8.81 |
| EV / EBIT | 9.63 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 3.13 |
| Debt / FCF | n/a |
| Interest Coverage | 3.72 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.10% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.88M |
| Profits Per Employee | 956,100 |
| Employee Count | 451 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:537291 has paid 28.01 million in taxes.
| Income Tax | 28.01M |
| Effective Tax Rate | 6.10% |
Stock Price Statistics
The stock price has decreased by -9.09% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -9.09% |
| 50-Day Moving Average | 150.44 |
| 200-Day Moving Average | 172.60 |
| Relative Strength Index (RSI) | 50.59 |
| Average Volume (20 Days) | 1,649 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:537291 had revenue of INR 4.46 billion and earned 431.20 million in profits. Earnings per share was 22.69.
| Revenue | 4.46B |
| Gross Profit | 3.18B |
| Operating Income | 452.63M |
| Pretax Income | 459.21M |
| Net Income | 431.20M |
| EBITDA | 494.37M |
| EBIT | 452.63M |
| Earnings Per Share (EPS) | 22.69 |
Balance Sheet
The company has 7.42 million in cash and 1.55 billion in debt, with a net cash position of -1.54 billion.
| Cash & Cash Equivalents | 7.42M |
| Total Debt | 1.55B |
| Net Cash | -1.54B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.80B |
| Book Value Per Share | 345.69 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.26%, with operating and profit margins of 10.16% and 9.68%.
| Gross Margin | 71.26% |
| Operating Margin | 10.16% |
| Pretax Margin | 10.31% |
| Profit Margin | 9.68% |
| EBITDA Margin | 11.09% |
| EBIT Margin | 10.16% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 1.31%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 1.31% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.82% |
| Shareholder Yield | 2.13% |
| Earnings Yield | 15.31% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |